Romero, Maritza J.
Toque, Haroldo A.
Caldwell, Ruth B.
Caldwell, Robert William
MetadataShow full item record
AbstractEndothelial dysfunction is a key event in the development of vascular disease, and it precedes clinically obvious vascular pathology. Abnormal activation of the RhoA/Rho kinase (ROCK) pathway has been found to elevate vascular tone through unbalancing the production of vasodilating and vasoconstricting substances. Inhibition of the RhoA/ROCK pathway can prevent endothelial dysfunction in a variety of pathological conditions. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of the ROCK pathway and its roles in endothelial dysfunction.
CitationJ Cardiovasc Dis Res. 2010 Oct-Dec; 1(4):165-170
- RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction.
- Authors: Denniss SG, Jeffery AJ, Rush JW
- Issue date: 2010 May
- Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
- Authors: Eisa-Beygi S, Wen XY
- Issue date: 2015 Feb
- The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
- Authors: Williams J, Bogwu J, Oyekan A
- Issue date: 2006 Jul
- Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.
- Authors: Priviero FB, Jin LM, Ying Z, Teixeira CE, Webb RC
- Issue date: 2010 Apr
- Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease.
- Authors: Bei Y, Duong-Quy S, Hua-Huy T, Dao P, Le-Dong NN, Dinh-Xuan AT
- Issue date: 2013 Oct